Fifty-four patients had their t0 samples analyzed with the SafeSEQ NGS breast cancer panel covering the coding regions of PIK3CA, ESR1, TP53, AKT, ERBB2, and KRAS. This evidence concerns the gene KRAS and breast carcinoma.